Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position.

The spectrum of hepatocellular proliferative lesions in B6C3F1 (C57BL/6N X C3H/HeN MTV-) mice used in National Toxicology Program (NTP) two-year carcinogenicity studies includes foci of cellular alteration, adenoma, carcinoma, and hepatoblastoma. The diagnosis of hepatocellular hyperplasia is reserved for those non-neoplastic proliferative lesions which are believed to occur secondary to necrosis or a degenerative process in the liver. Diagnostic criteria, similar to those previously published, are used during the NTP peer review of these lesions. Incidences of liver tumors in control mice have been established from the NTP database and the frequency of enhanced liver tumor responses in treated mice has been determined based on 278 two-year carcinogenicity studies. Although alternative rodent strains are being examined, at the present time there is no acceptable alternative to the B6C3F1 mouse for NTP carcinogenicity studies. Interim sacrifices and "stop" studies are incorporated into two-year studies to gain knowledge about the biological behavior of mouse liver neoplasia. Also, data are being gathered relative to the pattern of oncogene activation in spontaneous and chemically induced liver tumors in B6C3F1 mice.

[1]  T. Fox,et al.  Detection of a cellular oncogene in spontaneous liver tumors of B6C3F1 mice. , 1985, Science.

[2]  C. Frith,et al.  Hepatic cytologic and neoplastic changes in mice given benzidine dihydrochloride. , 1976, Journal of the National Cancer Institute.

[3]  R. Maronpot,et al.  Interpretation of Rodent Hepatocellular Proliferative Alterations and Hepatocellular Tumors in Chemical Safety Assessment1, 2 , 1982, Toxicologic pathology.

[4]  Joseph K. Haseman,et al.  Use of Historical Control Data in Carcinogenicity Studies in Rodents , 1984, Toxicologic pathology.

[5]  G. Boorman,et al.  Adenoma and Adenocarcinoma of the Gallbladder in Aged Laboratory Mice , 1986, Veterinary pathology.

[6]  L Tomatis,et al.  The predictive value of mouse liver tumour induction in carcinogenicity testing—a literature survey , 1973, International journal of cancer.

[7]  K. Rao,et al.  Morphology and metastatic nature of induced hepatic nodular lesions in C57BL x C3H F1 mice. , 1978, Cancer research.

[8]  G A Boorman,et al.  Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice. , 1985, Journal of the National Cancer Institute.

[9]  Ward Jm,et al.  A morphologic classification of proliferative and neoplastic hepatic lesions in mice. , 1979 .

[10]  R. Squire,et al.  Report of a workshop on classification of specific hepatocellular lesions in rats. , 1975, Cancer research.

[11]  D G Hoel,et al.  Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. , 1986, Cancer research.

[12]  A. Clark,et al.  Choline Deficiency, Partial Hepatectomy, and Liver Tumors in Rats and Mice , 1982, Toxicologic pathology.

[13]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[14]  J. Ward,et al.  The mouse liver tumor as an endpoint in carcinogenesis tests. , 1979, Toxicology and applied pharmacology.

[15]  T. Dunn,et al.  Malignant mouse-liver tumors resembling human hepatoblastomas. , 1973, Journal of the National Cancer Institute.

[16]  P. Newberne.  How Relevant Are Mice Hepatomas to Human Risk? , 1983, Toxicologic pathology (Print).

[17]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[18]  R. Maronpot,et al.  Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.